| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |